Skip to main content
Log in

Reply to Zaragori et al.: “Is IDH mutation status associated with 18F-FDopa PET uptake”

  • Letter to the Editor
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

The Original Article was published on 30 January 2020

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cicone F, Carideo L, Scaringi C, Arcella A, Giangaspero F, Scopinaro F, et al. 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma. Ann Nucl Med. 2019;33:295–302.

    Article  CAS  Google Scholar 

  2. Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, et al. IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas. Eur J Nucl Med Mol Imaging. 2017;44:1306–11.

    Article  CAS  Google Scholar 

  3. Ginet M, Zaragori T, Marie PY, Roch V, Gauchotte G, Rech F, et al. Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04509-y.

    Article  PubMed  Google Scholar 

  4. Carideo L, Minniti G, Mamede M, Scaringi C, Russo I, Scopinaro F, et al. 18F-DOPA uptake parameters in glioma: effects of patients' characteristics and prior treatment history. Br J Radiol. 2018;91:20170847.

    Article  Google Scholar 

  5. Cicone F, Carideo L, Minniti G, Scopinaro F. The mean striatal 18F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma. Eur J Nucl Med Mol Imaging. 2019;46:1051–3.

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Cicone.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cicone, F., Carideo, L., Scaringi, C. et al. Reply to Zaragori et al.: “Is IDH mutation status associated with 18F-FDopa PET uptake”. Ann Nucl Med 34, 230–231 (2020). https://doi.org/10.1007/s12149-020-01443-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-020-01443-0

Navigation